- Home
- ASMB vs FSHP Comparison
ASMB vs FSHP Comparison
Compare ASMB & FSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- FSHP
- Stock Information
- Founded
- ASMB 2005
- FSHP 2018
- Country
- ASMB United States
- FSHP United States
- Employees
- ASMB N/A
- FSHP N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- FSHP
- Sector
- ASMB Health Care
- FSHP
- Exchange
- ASMB Nasdaq
- FSHP NYSE
- Market Cap
- ASMB 139.8M
- FSHP 92.6M
- IPO Year
- ASMB 2010
- FSHP 2024
- Fundamental
- Price
- ASMB $18.70
- FSHP $10.44
- Analyst Decision
- ASMB Strong Buy
- FSHP
- Analyst Count
- ASMB 3
- FSHP 0
- Target Price
- ASMB $33.00
- FSHP N/A
- AVG Volume (30 Days)
- ASMB 43.5K
- FSHP 1.0K
- Earning Date
- ASMB 08-07-2025
- FSHP 01-01-0001
- Dividend Yield
- ASMB N/A
- FSHP N/A
- EPS Growth
- ASMB N/A
- FSHP N/A
- EPS
- ASMB N/A
- FSHP 0.21
- Revenue
- ASMB $32,154,000.00
- FSHP N/A
- Revenue This Year
- ASMB $0.04
- FSHP N/A
- Revenue Next Year
- ASMB N/A
- FSHP N/A
- P/E Ratio
- ASMB N/A
- FSHP $49.13
- Revenue Growth
- ASMB 148.33
- FSHP N/A
- 52 Week Low
- ASMB $7.75
- FSHP $9.99
- 52 Week High
- ASMB $19.93
- FSHP $10.48
- Technical
- Relative Strength Index (RSI)
- ASMB 65.84
- FSHP N/A
- Support Level
- ASMB $18.01
- FSHP N/A
- Resistance Level
- ASMB $18.99
- FSHP N/A
- Average True Range (ATR)
- ASMB 0.84
- FSHP 0.00
- MACD
- ASMB -0.05
- FSHP 0.00
- Stochastic Oscillator
- ASMB 84.42
- FSHP 0.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.